← Leaderboards
Sangeeta Goswami
University Of Tx Md Anderson Can Ctr
$1,386,369
Attributed
$1,386,369
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $470K · FY2023–25$500K$375K$250K$125K$0
'23
'24
'25
Funding mix
By agency
NIH$1,386,369 · 1
By mechanism
R37$1,386,369 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Michael Davies$11,575,720
- Min Gyu Lee$8,063,863
- Heath Devin Skinner$8,539,031
- Candelaria Gomez-Manzano$2,523,797
- Ferdinandos Skoulidis$4,461,361
Others in their field
Other Rising Stars on “Antigen Presentation”
- Jason Dickens · Duke University$12,259,409
- Weston Daniel · Evoq Therapeutics, Inc.$4,557,243
- Xiaoxiao Wan · Washington University$3,667,189
- Magnus Adrian Gero Hoffmann · California Institute Of Technology$3,559,750
- Dmitriy Zamarin · Sloan-Kettering Inst Can Research$3,427,557
- Jasdave Chahal · Tiba Biotech, Llc$3,297,330
Research focus
Antigen PresentationAffectAnti-Pd1 TherapyAutomobile DrivingAntigen Presentation PathwayBrain NeoplasmsCd8-Positive T-LymphocytesCell Differentiation ProcessCell PhysiologyCellsBiological ModelsCellular BiologyCheckpoint TherapyChip-SeqChromatinCombinatorialCombined Modality TherapyDendritic CellsDetectionEffective TherapyEffector T CellEfficacy EvaluationEnzymesEpigenetic Process
Grant awards (3)
Targeting epigenetic machinery to overcome myeloid cell-mediated resistance to anti-PD-1 therapy in GBM$469,956
R37 · FY2025 · CA · contact PI
Targeting epigenetic machinery to overcome myeloid cell-mediated resistance to anti-PD-1 therapy in GBM$446,457
R37 · FY2024 · CA · contact PI
Targeting epigenetic machinery to overcome myeloid cell-mediated resistance to anti-PD-1 therapy in GBM$469,956
R37 · FY2023 · CA · contact PI